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Abstract
Myxomatous mitral valve disease (MMVD) is the most common heart dis-
ease in dogs and has many similarities to human mitral valve prolapse (MVP). 
Transthoracic echocardiography is a non-invasive method for making a diagnosis 
and predicting the progression of heart failure (HF) in dogs and humans with 
mitral regurgitation (MR). It enables clinicians to detect the mitral valve (MV) 
lesions, to evaluate MR severity, and to assess its impact on cardiac remodeling, 
myocardial function, left ventricular (LV) filling pressures, as well as pulmonary 
arterial pressure. Furthermore, advanced ultrasound technologies such as tissue 
Doppler imaging (TDI), strain and strain rate imaging, and two-dimensional (2D) 
speckle tracking echocardiography (STE) provide a better assessment of global 
and regional myocardial function. Although the severity of MR and HF in dogs 
with MMVD is being evaluated as similar to human cardiology, the veterinary 
cardiologists are more focused on the severity of cardiac remodeling and cardiac 
dysfunction caused by MR, because surgical restoration of defected mitral appara-
tus is rarely done in dogs. The chapter will review conventional echocardiographic 
features of MMVD in dogs to provide a better understanding of the similarities and 
discrepancies between canine MMVD and human MVP to veterinary and human 
cardiologists and researchers.
Keywords: mitral valve prolapse, myxomatous mitral valve disease, mitral valve 
insufficiency, heart failure, mitral regurgitation
1. Introduction
Myxomatous mitral valve disease (MMVD) accounts for 75–80% of heart 
diseases in dogs and is more prevalent in small and elderly dogs [1, 2]. Due to 
similarities to human mitral valve prolapse (MVP), it gains huge interest in vet-
erinary and human cardiologists. MMVD and MVP are characterized by progres-
sive myxomatous degeneration of atrioventricular valves and subsequent mitral 
regurgitation (MR) [3], causing left atrial (LA) and left ventricular (LV) volume 
overload and left-sided congestive heart failure (CHF) [4]. Although there are 
many similarities in both diseases (e.g. macroscopic and microscopic pathology, 
strong genetic background, marked effect of age on prevalence and severity, slow 
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progression), discrepancies in these two diseases (e.g. much more prevalent in dogs 
than in humans, less prone to develop endocarditis in dogs, less prominent systolic 
clicks in dogs) exist [5].
Although there are many diagnostic methods for MMVD, the standard trans-
thoracic echocardiographic examination is a gold standard test for diagnosis and 
prognosis of MMVD and MVP in dogs and humans, respectively. The echocardiog-
raphy is non-invasive and enables the clinicians to detect the mitral valve (MV) 
lesions, to evaluate MR severity, and to assess its impact on cardiac remodeling, 
myocardial function, left ventricular filling pressures, as well as pulmonary arte-
rial pressure [6–11]. However, conventional ultrasound imaging modalities such as 
two-dimensional (2D), M-mode, color Doppler, pulse-wave (PW), and continuous-
wave (CW) Doppler echocardiography may not be enough to precisely evaluate 
the severity of mitral valve diseases and to monitor disease progression. Advanced 
ultrasound technologies such as tissue Doppler imaging (TDI), strain and strain 
rate imaging, and two-dimensional speckle tracking echocardiography (STE) gain 
popularity in veterinary and human cardiologists because these technologies can 
assess and monitor global and regional myocardial function more precisely [12], 
although those require more expensive ultrasound machine and training.
Human MVP causing MR is divided into two groups: primary (i.e. structural 
intrinsic valvular disease) and secondary (i.e. nonstructural functional MR caused 
by non-mitral valve diseases). Like dogs, causes of primary MR are degenerative 
diseases on the mitral valve, such as Barlow, fibroelastic degeneration, Marfan, 
Ehlers-Danlos, and annular calcification, although rheumatic disease and toxic val-
vulopathy can also cause MR in humans [13]. Severity of MR in humans is graded 
qualitatively (e.g. mitral valve morphology, color flow MR jet, flow convergence 
zone, CW signal of MR jets), semi-quantitatively (e.g. vena contracta [VC] width, 
pulmonary vein flow, mitral inflow, TVI mit/TVI Ao), and quantitatively (effective 
regurgitant orifice area [EROA], regurgitant volume [R Vol]) [13]. LV and LA size 
and the systolic pulmonary arterial pressure are also used to determine the severity 
of CHF caused by MR.
Although the severity MR and CHF in dogs with MMVD are being evaluated as 
similar to human cardiology, the veterinary cardiologists are more focused on the 
severity of cardiac remodeling (e.g. LA and LV dilation) and cardiac dysfunction 
caused by MR, because surgical restoration of defected mitral apparatus is rarely done 
in dogs. Therefore, the echocardiographic indices related to MR severity (e.g. MV 
morphology, flow convergence zone) are not routinely assessed in dogs with MMVD.
The chapter reviews conventional echocardiographic indices being used for 
diagnosis and prognosis of canine MMVD to provide a better understanding of the 
similarities and discrepancies between canine MMVD and human MVP to veteri-
nary and human cardiologists and researchers.
2. Assessment of MR severity
Echocardiography is a gold standard test in the assessment and management of 
humans and dogs with MR. Although color flow MR jets and CW signal of MR jets 
are useful for detecting MR, a more quantitative approach is required for determin-
ing the severity of MR in humans and dogs.
2.1 Semi-quantification of MR
Although quantitative assessment of MR (e.g. EROA and R Vol) is being used 
for grading the severity of MR in humans [13], it is rarely used in canine practice, 
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because it requires more time-consuming interrogation and is often hard to define 
the location of EROA and flow convergence shape in dogs with MR [14]. Therefore, 
canine study, especially in practice, focuses more on the semi-quantification of MR 
(e.g. the maximal ratio of the regurgitant jet area signal to LA area [ARJ/LAA ratio] 
and vena contracta).
The ARJ/LAA ratio can be easily obtained with the color Doppler imaging (CDI) 
method and showed good repeatability and reproducibility in dogs [15, 16]. MR 
can be graded as mild (<30%), moderate (30–70%), or severe (>70%), based on 
the ARJ/LAA ratio on the CDI study in dogs with MMVD (Figure 1A) [15, 16]. 
Unfortunately, the ARJ/LAA ratio can be affected by many intrinsic factors (e.g. 
SAP, LA pressure, the spatial orientation of MR jet) and extrinsic factors (e.g. pulse 
repetition frequency and gain settings) [17]. Several studies found the ARJ/LAA ratio 
was not closely correlated with the severity of MMVD in dogs, especially in dogs with 
American College of Veterinary Internal Medicine (ACVIM) B2 and C [18, 19].
The vena contracta is the narrowest width of the MR jet that occurs at or 
just downstream from the regurgitant orifice and can reflect the severity of 
MR (obtained from measuring the regurgitant orifice size by the CDI study) 
(Figure 1B) [17]. Although it requires less time-consuming interrogation and is 
technically easier to obtain, this method is prone to errors, especially in dogs having 
dynamic regurgitant orifices [14]. Several studies found the VC and VC-derived 
variables were closely correlated with the severity of MR and survival time in dogs 
with MMVD [20–22]. One study found the mean (±SD) diameter of the mitral 
regurgitation vena contracta in a right parasternal long-axis (RPLx) view (VCR:Ao) 
and a left apical four-chamber view (VCL:Ao) indexed to aortic diameter were 
0.21 ± 0.14 and 0.24 ± 0.12, respectively, in dogs with MMVD [21]. Furthermore, 
the VCL:Ao > 0.24 was closely correlated with survival time (hazard ratio 4.87) [21].
2.2 Quantification of MR
The measurement of the flow convergence area by proximal isovelocity surface 
area (PISA) is a gold standard method to quantify the MR jet in humans [13]. 
Although one study found the PISA method was repeatable and reproducible 
in awake dogs [16], it is more time-consuming and requires several precautions 
to obtain the optimal acquisition of the flow convergence images in dogs with 
MMVD [14]. The regurgitation fraction (RF) obtained by the PISA can be used for 
Figure 1. 
(A) Semi-quantification of mitral regurgitation (MR). The maximal ratio of the regurgitant jet area signal to 
the left atrial area (ARJ/LAA ratio) was obtained from a left apical four-chamber view. The ARJ (1.12 cm2)/
LAA (2.12 cm2) of this case was 53%, indicating moderate MR. (B) the vena contracta diameter from a 
left apical four-chamber view (VCL) was measured as the diameter of the narrowest point of the mitral 
regurgitation jet, downstream of the region of proximal flow convergence.
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determining the severity of MR in dogs (e.g. mild if <30%, moderate if 30–75%, 
and severe if >75% of RF). Several studies found the RF was closely correlated 
with the severity of MMVD and other echocardiographic variables (e.g. LA/Ao and 
systolic PA pressure) [16, 23, 24]. However, one study found the MR quantification 
of the PISA method showed a wide range of RF (~33% asymptomatic MMVD dogs 
had moderate to severe RF) and thus is not routinely done in canine practice [16].
3. Assessment of left heart remodeling
Chronic and hemodynamically significant MR can cause LA and LV volume 
overload, leading to subsequent LA and LV enlargement. The severity of LA and LV 
remodeling can be assessed by LA to aortic root ratio (LA/Ao), indexed LA diam-
eter (iLA), LV end-diastolic internal dimension to aortic root ratio (LVID/Ao), and 
normalized LV end-diastolic internal dimension (nLVID).
3.1 LA assessment
Estimation of LA diameter is one of the best predictors of outcome in dogs with 
MMVD [25, 26]. It also enables to make a decision for the initiation of medication 
in dogs with preclinical MMVD (ACVIM B1 and B2) and to estimate the risk for 
development of left-sided CHF [27, 28]. Hemodynamically significant chronic MR 
generally induces LA volume overload and thus leads to increase in LA volume [29].
In dogs with MMVD, MR causes LA and LV dilation, and thus the assessments 
of LA and LV chamber dimensions enable clinicians to predict the progression of 
MMVD and risk of CHF [27, 30–33]. One study evaluated the linear dimensions of 
the LA, LV, and Ao from the right parasternal long-axis view in dogs with MMVD 
and found that the mean (standard deviation; SD) for LA/LV, LV/Ao, and LA/Ao in 
dogs with MMVD were 1.1 (±0.09), 2.7 (±0.5), and 3.0 (±0.5), respectively, com-
pared with 1.0 (±0.05), 2.1 (±0.2), and 2.1 (±0.1), respectively, in healthy control 
dogs [34]. This study showed good applicability and repeatability of the LA/LV, LV/
Ao, and LA/Ao for assessing LV and LA enlargement in dogs with MMVD [34].
Conventional echocardiographic marker assessing LA enlargement is LA/Ao at the 
aortic root level of LV short-axis plane (Figure 2A and B). The degree of LA dilation 
is closely related to the progression of CHF and survival time in both symptomatic 
and asymptomatic dogs with MMVD [23, 25, 35]. One study enrolled in 558 dogs with 
MMVD found LA/Ao > 1.7 was the only significant prognostic index among echocardio-
graphic indices [25]. Although the LA/Ao is a major echocardiographic index for deter-
mining the degree of LA dilation, the method for measuring the diameter of Ao is not 
standardized. The first method assessing LA size [36] was as follows: step 1 measures the 
internal short-axis diameter of the Ao along the commissure between the noncoronary 
and right coronary aortic valve cusps on the first frame after aortic valve closure and 
step 2 measures the internal short-axis diameter of the LA in the same frame in a line 
extending from and parallel to the commissure between the noncoronary and left coro-
nary aortic valve cusps to the distant margin of the left atrium (Figure 2A). However, 
many other studies used a different way of measurement (the second method), i.e. 
measuring the internal short-axis diameter of the Ao along the commissure between the 
noncoronary and left coronary aortic valve cusps on the first frame after aortic valve clo-
sure (Figure 2B). Our study found the Ao diameters measured by the first method were 
longer than those measured by the second method. Therefore, the LA/Ao measured by 
the first method was smaller [37]. Because the LA/Ao is a major echocardiographic index 
for selecting MMVD study groups for drug trials and clinical trials, the standardization 
of measurement of Ao diameter is required in the future study.
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To overcome the problem of LA/Ao at the short axis (LA/AoSx), the LA/Ao was 
also measured at the long axis (LA/AoLx) [34]. The method measuring LA/AoLx 
standardized and thus minimized the inconsistency of measurement of LA and Ao 
(Figure 2C and D). Several canine studies found cut-offs for LA/AoLx > 2.6 and 
LA/AoSx > 1.6 indicate hemodynamically relevant MMVD and timing of therapeu-
tic intervention (e.g. enalapril and pimobendan administration) [27, 33].
Indexed LA diameter (iLA) is a good alternative for assessing LA dilation 
[19]. The iLA is calculated by using the following formula: LA diameter (mm)/
(0.795 × body weight [kg])1/3. In this study, the iLA diameter had higher sensitivity 
and specificity for detecting heart disease (healthy control vs. ACVIM B2), despite 
lower specificity for detecting heart failure (ACVIM B vs. ACVIM C) in dogs with 
MMVD. Cut-off for iLA > 12.7 indicates the risk of heart failure (ACVIM C) in dogs 
with MMVD [19].
Because the actual structure of LA is three-dimensional (3D), the LA dilation 
may occur in all direction (e.g. cranio-caudal, medio-lateral, and ventrodorsal). 
Therefore, the degree of LA dilation may be overestimated or underestimated, 
depending on the direction of LA dilation [38, 39]. For this reason, traditional 
estimation of LA diameter using 2D assessment of LA with linear methods (e.g. 
LA/AoSx, LA/AoLx, iLA) may not be enough to provide an accurate and consistent 
measurement. One study measured the LA volume to detect mild LA enlargement 
using the three-dimensional echocardiography (3D-EC) and found this method 
Figure 2. 
The method for measurement of left atrial to aortic root ratio (LA/Ao). (A) A LA/Ao obtained from a right 
parasternal short axis (LA/AoSx) by method 1 (see text). (B) A LA/Ao obtained from a right parasternal 
short axis (LA/AoSx) by method 2 (see text). (C and D) A LA/Ao obtained from a right parasternal long axis 
(LA/AoLx). For LA diameter (C), the measurement was made at end-systole 1 to 2 frames before the opening 
of the mitral valve leaflets. The measurement bisects the atrium extending from the mid-atrial septum in the 
near field to the bright pericardial echo of the LA lateral wall in the far field and is roughly parallel to the 
mitral annulus. For Ao diameter (D), the measurement of the aortic valve was made between the opened aortic 
valve leaflets in an early systolic frame when the Ao diameter is the greatest.
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provided a more accurate measurement of LA size than the 2D echocardiography 
(2D-EC) [40]. Furthermore, the estimation of LA diameter and area by the 2D-EC 
was shown to have a poor correlation with the 3D-LA volume in humans [41]. 
However, it is more time-consuming, and substantial off-line analysis is required. 
Furthermore, the 3D-EC underestimated the LA volumes compared with magnetic 
resonance imaging (MRI) in human patients [42].
The area-length method (ALM; Figure 3A) or monoplane or biplane Simpson’s 
modified method of discs (SMOD; Figure 3B) is currently recommended to 
measure LA area derived from the LA volume [43–46]. In human, the biplane 
method from four- and two-chamber views is preferred to measure the LA volume 
[47]. One study evaluated the difference of LA volume measurement by compar-
ing 3D-LA volume measurement to two different 2D-LA volume measurements 
(using the SMOD and ALM) [48]. In this study, the SMOD and ALM systemati-
cally underestimated the LA volume by 7% and overestimated by 24%, respec-
tively, compared with 3D-LA volume (Figure 3C). One human study also found 
the SMOD underestimated the LA volume compared to the 3D-LA volume [49]. 
Therefore, the 2D-SMOD may be a better method for the estimation of LA volume, 
if the 3D-EC is not available. One study found the LA volume indices including LA 
maximal volume (LAVmax) and LA minimal volume (LAVmin) using the ALM 
was useful to predict survival time when cardiac-related death was only consid-
ered [50]. In this study, the LAVmax > 3.53 mL/kg indicated high mortality risk in 
dogs with MMVD.
Figure 3. 
Left atrial (LA) volume measured for three different methods at a left apical four-chamber view. (A) Area-
length method (ALM), (B) Simpson’s modified method of discs (SMOD), (C) real-time three-dimensional 
echocardiography (RT3DE).
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Evaluation of the LA function may help to determine the severity of heart failure 
in dogs with MMVD [40, 44]. The LA function consists of three components: it acts 
as a reservoir for pulmonary venous (PV) return during ventricular systole (atrial 
diastole), as a conduit for the passage of stored blood from LA to LV during early 
ventricular diastole and diastasis, and as an active pump delivering 15–30% of LV 
filling during late ventricular diastole (atrial systole) [51]. One study established 
reference intervals for the LA function using 2D linear and area-based estimates 
and evaluated the diagnostic value to differentiate dogs with asymptomatic 
(ACVIM B) from symptomatic (ACVIM C) MMVD [52]. This study evaluated four 
LA functional indices (Figure 4): the LA expansion index for LA reservoir, the LA 
active emptying fraction for LA contractile, the LA passive emptying fraction for 
LA conduit, and the LA total emptying fraction for LA reservoir. This study dem-
onstrated estimates of LA function except LA passive emptying fraction worsened 
with the severity of heart failure, although these indices were not sensitive enough 
to differentiate dogs with asymptomatic from symptomatic MMVD [52].
3.2 LV assessment
Chronic and hemodynamically significant MR can lead to the enlargement 
of the LV dimension. The degree of LV dilation was strongly correlated with the 
severity of heart failure in dogs with MMVD [53]. The LV internal dimension can 
be measured from the 2D or M-mode echocardiography by freezing the image at the 
Figure 4. 
Two-dimensional echocardiographic estimates of left atrial function. (A) the minimal left atrial diameter/
area was obtained at the first frame after mitral valve closure (late ventricular diastole), (B) maximal left 
atrial diameter were obtained at the last frame before opening of the mitral valve (early ventricular diastole), 
and (C) the mid-left atrial diameter/area was obtained at the onset of the p-wave on the ECG (diastasis).  
(D) The formula for LA function index.
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end-diastole and the end-systole (Figure 5). As described above, the LV internal 
dimension was significantly larger in dogs with MMVD [34]. However, the LV 
dimensions noticeably vary among breeds of dogs. Therefore, one study evaluated 
the allometric scaling of M-mode cardiac measurements in normal adult dogs and 
found a good correlation between M-mode measurements and BW after logarithmic 
transformation of the data [54]. Therefore, the M-mode-derived LV internal dimen-
sion at systole (LVIDs) and diastole (LVIDd) can be transformed into body weight-
indexed (normalized) LV internal dimension using the following formulas to obtain 
a more accurate estimation of LV dilation in dogs with MMVD:
• LV end-diastolic diameter normalized for body weight (LVIDdN) = LVIDd 
(cm)/weight (kg)0.294
• LV end-systolic diameter normalized for body weight (LVIDsN) = LVIDs (cm)/
weight (kg)0.315
LVIDdN ≥1.7 indicates dogs requiring cardiac medication (>ACVIM B2) [55].
Several studies also found that body surface area (BSA) indexed LV dimensions 
including end-diastolic index (EDVI) and end-systolic volume index (ESVI) could 
detect myocardial systolic dysfunction in dogs with MMVD [10, 11, 56]. The EDVI 
and ESVI can be obtained by the Teichholz formula [57]:
• EDVI = [7 × (LVIDd)3/(2.4 + LVIDd)]/BSA
• ESVI = [7 × (LVIDs)3/(2.4 + LVIDs)]/BSA
End-diastolic volume index and end-systolic volume index are obtained by 
dividing BSA, respectively [57]. Normal values of EDVI and ESVI are <100 and 
<30 mL/m2, respectively [57]. One study evaluated the diagnostic accuracy of ESVI 
using two different methods (i.e. the geometric [GM, based on Teichholz formula] 
and two planimetric methods [PM, Simpson’s derived and area-length methods]) 
and found that the GM overestimates ESVI in a nonlinear way [11]. However, the 
Figure 5. 
Measurement of left ventricular internal dimension. (A) M-mode echocardiography obtained from a right 
parasternal short axis at the papillary muscle level and (B and C) 2D echocardiography obtained from a right 
parasternal long axis at systole (B) and diastole (C).
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ESVI was correlated with the severity of CHF in dogs with MMVD [11]. A recent 
study also found the EDVI and ESVI obtained from the GM were overestimated and 
had poor diagnostic values in dogs with MMVD [19]. To overcome this limitation, 
the veterinary Teichholz formula has been proposed (Table 1).
Because sole use of LV dimension often leads to the misestimation of LV dila-
tion, the 2D and M-mode-derived LVIDd/Ao ratio is more appropriate and simpler 
for evaluating the degree of LV enlargement [14]. However, a recent study found the 
LVIDd/Ao ratio had high specificity and low sensitivity for detecting asymptomatic 
dogs from healthy control dogs and symptomatic dogs from asymptomatic dogs 
with MMVD [19].
Due to the LV dilation, the sphericity of the LV can be increased. One study 
revealed a significant decrease in the LV sphericity index in dogs with advanced 
MMVD [11]. The LV sphericity index can be calculated by the ratio of LV end-dia-
stolic length (at left apical two- or four-chamber plane; Figure 6A) to the M-mode 
LV end-diastolic diameter (Figure 6B).
4. Assessment of myocardial dysfunction
LV systolic function can be reduced on serial 2D-EC in some dogs with MMVD 
[10], as noticed in human with advanced CHF [58]. However, LV measurement for 
systolic function often complicates depending on the LV loading condition, and 
thus fractional shortening (%FS) and LV ejection fractions (%LVEF) are often 
increased in dogs with advanced MMVD. In many cases of canine MMVD, when 
cardiac output is reduced with the progression of MMVD, the LV wall motion 
becomes more hyperdynamic [10]. Therefore, echocardiographic indices with 
Doppler for assessing LV functions and filling pressures are often ambiguous by 
age-related impairment of LV relaxation, LA pressure overload by MR, and impact 
Figure 6. 
The left ventricular (LV) sphericity index was calculated by the ratio of LV end-diastolic length (at left apical 
four-chamber plane; A) to the M-mode LV end-diastolic diameter (B).
Dog
Diastolic volume LVd3 X 7/[2.4 + 3.7 X LVd/(0.795 X W1/3)]
Systolic volume LVs3 X 7/[2.4 + 5.9 X LVs/(0.795 X W1/3)]
LVd, Left ventricle end-diastolic diameter (in cm); LVs, left ventricle end-systolic diameter (in cm); W, weight in 
kilograms. From “Clinical Echocardiography of the Dog and Cat - E-Book (edited by Madron E, Chetboul V and 
Bussadori C), St Louis: Elsevier; 2016. pp. 115.
Table 1. 
Veterinary Teichholz method formulas for dogs.
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on myocardial tissue velocities by LV loading condition. Therefore, echocardio-
graphic indices for LV systolic and diastolic function often lead to the misinterpre-
tation of LV function.
4.1 %FS and %LVEF
LV remodeling caused by chronic and hemodynamically significant MR is 
characterized by changes in LV geometry in response to chronic volume overload. 
The common echocardiographic indices for LV systolic myocardial function are 
%LVEF and %FS. The EF is the volumetric fraction of blood ejected from the LV in 
each heartbeat (LVEF = [end-diastolic volume − end-systolic volume]/end-diastolic 
volume × 100). The %FS is defined by the percent change in the dimension from 
end-diastole to end-systole (FS% = [LVIDd − LVIDs]/LVIDd × 100) [59]. As dis-
cussed earlier, %FS and %LVEF are reduced in human with myocardial dysfunction 
[58]; they are often increased in dogs with advanced MMVD due to hyperdynamic 
LV contraction from elevated preload and reduced afterload [19, 56]. Therefore, 
these two indices do not have good diagnostic value for detecting the progression of 
heart failure in dogs with MMVD [19].
4.2 Spectral Doppler studies
More advanced Doppler and tissue echocardiographic methods are being used 
for detecting LV dysfunction in dogs with MMVD to overcome problems encoun-
tered with the simple measurement of LV geometry.
Continuous-wave Doppler interrogation of MR flow profile can be affected by 
LA pressure, LV systolic function, and loading condition as well as systemic arterial 
pressure (SAP) (Figure 7A). Although the peak velocity of MR is closely related to 
MR fraction in the LA but not related to the severity of MMVD in dogs [19], dogs 
with LV systolic impairment and high LA pressure (as well as markedly reduced 
SAP) may have decreased peak MR velocity [14]. This may help to differentiate 
dogs with end-stage CHF from those with ACVIM C and D MMVD. Asymmetric 
MR flow profiles and a cut-off sign in mid to late systole are often noticed in dogs 
with the advanced stage of MMVD and are caused by reduction in MR flow due 
to high LA pressure (Figure 7B). The dp/dt is the rate of pressure change over 
time during isovolumic contraction and closely related to LV systolic function in 
humans (Figure 7A) [60]. However, the dp/dt in dogs with MMVD has limited 
Figure 7. 
Continuous-wave (CW) Doppler flow profile obtained from dogs with severe mitral regurgitation (MR). (A) 
The MR peak velocity and pressure gradient were 5.69 m/s and 129.5 mmHg, respectively, in this dog. (B) 
Asymmetric MR flow profiles and cut-off signs (arrow) in mid to late systole obtained from the advanced stage 
of mitral valve disease (see text).
11
Echocardiographic Features in Canine Myxomatous Mitral Valve Disease: An Animal Model…
DOI: http://dx.doi.org/10.5772/intechopen.91819
value, because most MMVD dogs may have high peak velocity and asymmetric MR 
profiles, regardless of the severity of MMVD [18], although some authors proposed 
its use for detecting LV systolic function [2].
Pulse-wave Doppler interrogation of transmitral flow profile is closely correlated 
with the stage of MMVD in dogs [14, 18, 19]. The transmitral flow profile consists 
of an early E-peak (rapid LV filling) and a late diastolic A-peak (atrial contraction) 
and is closely related to diastolic LV function (LV relaxation/compliance, LV volume 
overload/pressure overload, and recoil) as well as LV filling pressure (Figure 8A) 
[61, 62]. Although E/A reversal (E/A < 1) is common in the aged canine popula-
tion, E-peak is higher than A-peak in general canine population (i.e. E/A < 1). One 
study found 0.87 ± 0.13 m/s (E-peak) and 0.61 ± 0.12 m/s (A-peak) in 100 healthy 
dogs [63]. A high-velocity E-peak (>1.5 m/s) indicates marked elevation of LA 
pressure [10] and is correlated with severity of CHF and survival time in dogs with 
MMVD [18, 19, 23, 25]. Generally, a higher E-peak with a shorter E deceleration 
time (<80 ms in dogs older than 10–12 years) indicates marked LA pressure over-
load and non-compliant LV, while an E/A ratio <1 and/or a prolonged E deceleration 
time indicates impaired relaxation [10]. Because the E-peak velocity is increased 
with the elevation of LA pressure whereas decreased with impairment of LV relax-
ation, transmitral flow profile sometimes misleads the severity of LV myocardial 
dysfunction. However, myocardial and annular velocities are less load-dependent 
than transmitral flow profile, and thus the E/e (the early longitudinal mitral 
annular velocity measured by tissue Doppler imaging) ratio is found to better reflect 
LV filling pressure in dogs with MMVD [61]. A decrease in e-peak at mitral annulus 
Figure 8. 
Transmitral E/e ratio and E/IVRT (the isovolumic relaxation time). (A and B) Transmitral E-peak obtained 
from a left apical four-chamber plane and tissue Doppler imaging of lateral e-peak obtained from a left 
apical four-chamber plane. (C and D) Transmitral E-peak obtained from a left apical four-chamber plane. 
By moving sampling gate towards the midline of the aorta and mitral annulus, aortic and mitral flows were 




indicates impaired relaxation. One study revealed an E/e ratio >9 was equivalent 
to >20 mmHg of LA pressure (95% probability in a canine model of acute MR) 
(Figure 8B) [61]. Furthermore, >12 of E/e along with a high E-peak velocity was 
able to detect the presence of CHF in this study population [61]. One recent study 
also demonstrated an E/e cut-off value of 13 identifies CHF with high sensitivity 
(80%) and high specificity (83%) [64]. Although the e-peak is less affected by LV 
loading condition, it can be also affected by age and severe LV volume overload, 
and thus the E/e ratio may have limited value in this situation [14]. Several studies 
demonstrated E-peak/isovolumic relaxation time (E/IVRT) was correlated with 
LA pressure and end-diastolic LV pressure in dogs (Figure 8C and D) [62, 65, 66]. 
The IVRT may be decreased with the elevation of LV filling pressure. One study 
suggested the E/IVRT ratio >2.5 and an IVRT <45 ms might indicate the presence of 
CHF in dogs with advanced MMVD [62]. PW Doppler interrogation of the pulmo-
nary venous flow profile gains popularity to determine LA volume and pressure 
overload by severe MR in humans [67]. However, it has limited value in dogs with 
MMVD, due to technical difficulty (e.g. PV usually locates at the far-end of an echo-
cardiographic window) and poor-quality PV profiles (e.g. MR flow often enters into 
the PV) [14]. The LV Tei index (LV Tei = [IVRT + IVCT + LVET]/LVET, IVCT stands 
for the isovolumic contraction time) is a valuable index for detecting LV systolic 
and diastolic dysfunction simultaneously in human with CHF (Figure 9) [68]. A 
human study found shortened LVET/increased LV Tei index in patients with systolic 
dysfunction and increased mitral valve closure time and Tei index in humans with 
diastolic dysfunction [69, 70]. One canine study found the LV Tei was closely related 
to LV dp/dt and was increased with the severity of MMVD [71]. However, in dogs 
with moderate to severe MR, the IVRT and IVCT are often too short or not detect-
able [14]. Therefore, the Tei index is rarely used in veterinary fields.
5. Assessment of pulmonary hypertension
Pulmonary venous hypertension (PVH) is a common cause of pulmonary hyper-
tension (PH) in dogs and is prevalent in dogs with MMVD, especially in dogs with the 
advanced stage of CHF [7, 62, 72]. Gold standard methods detecting PH in dogs are 
Doppler assessment of peak tricuspid regurgitation (TR) and pulmonic regurgitation 
(PR) jet velocities [7]. One study demonstrated the Doppler evidence of PH was more 
evidenced in dogs with more advanced MMVD [7]. Another study also found that 
dogs having moderate to severe PH had a poorer outcome than in MMVD dogs [72].
Figure 9. 
Two methods for measuring left ventricular (LV) Tei index. (A) Tissue Doppler imaging at the mitral annulus 
and (B) Pulse-wave Doppler interrogation at the midline of the aorta and mitral annulus (see Figure 8D for 
the measurement). (See text for more information).
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5.1 Doppler interrogation of TR and PR jets
The peak velocity of TR jet (obtained from either a right parasternal short-axis 
view or a left parasternal four-chamber view) represents the systolic pulmonary 
artery pressure (sPAP) if there is no right ventricular outflow tract (RVOT) 
obstruction [73]. The systolic pulmonary artery pressure can be calculated by 
applying the modified Bernoulli equation (ΔP = 4 × velocity2) to the peak velocity 
of TR (Figure 10A) or PR jets (Figure 10B) and adding the right atrial pressure 
(RAP): ΔP + π right atrium. The estimated right atrial pressure is 5 mmHg in 
dogs without any evidence of RA dilation; 10 mmHg in dogs with evidence of 
RA dilation, but no signs of right-sided heart failure (R-HF); and 15 mmHg in 
dogs with evidence of RA dilation and clinical signs of R-HF. Then mean pulmo-
nary arterial pressure (mPAP) can be calculated using the following equation: 
mPAP = 0.61 × sPAP +2. In dogs having the only PR, the mPAP can be calculated 
using the following equation: PR peak pressure gradient + RAP. A mPAP <25 mmHg 
is considered normal, while mPAP 25–40 (equivalent to 2.8–3.4 m/s of peak TR 
velocity), 41–55 (3.4–4.3 m/s), and >55 mmHg (>4.3 m/s) are considered mild, 
moderate, and severe, respectively [73]. Because the peak velocity is closely cor-
related with the beam alignment of jet, it often underestimates the severity of PH, 
if the beam is not parallel to jet [18]. Another study also claimed that the Doppler 
estimation of SAP often overestimated PH in dogs with MMVD [73]. Since some 
dogs with PH may have no or insufficient Doppler evidence of PH (e.g. TR or PR 
jets), other echocardiographic evidence of PH should be pursued in dogs having 
R-CHF signs or persistent coughing [14]. Despite these limitations, canine studies 
found the SAP showed good prognostic value for detecting the progression of CHF 
and the survival time in dogs with MMVD [7, 62, 72].
5.2 2D-EC evidence of PA/RVOT dilation
The 2D-EC evidence of PA/RVOT dilation is the simplest way to detect the 
existence of PH in dogs with MMVD [35, 74–77]. Since chronic pressure overload 
and volume overload in RV can cause RV concentric hypertrophy (thickened 
RV free wall) and eccentric hypertrophy (RV dilation), respectively, simple 2D 
measurements of RV free wall thickness and dimension may help to identify dogs 
with PH [74, 78]. Furthermore, LV eccentricity (obtained from right parasternal 
short-axis view at papillary level; a ratio of longitudinal to the transverse length of 
LV chamber; Figure 11C) is also a simple echocardiographic index for detecting the 
existence of PH in dogs [78]. Two studies found the LV eccentricity becomes <1, as 
Figure 10. 
Echocardiographic evidence of pulmonary hypertension. Continuous-wave Doppler study showing severe 
tricuspid regurgitation (A) and pulmonic regurgitation (B). (See text for more information).
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the RV pressure becomes higher than the LV pressure (as commonly seen in dogs 
with PH) [74, 79].
In normal dogs, the diameters of the main pulmonary artery (MPA) are roughly 
identical, and thus MPA/Ao ratio should be close to 1 (Figure 11D). Therefore, MPA/Ao 
ratio > 1 indicates the PA dilation meaning the existence of PH, unless there is RVOT 
obstruction. Many studies revealed the dilation of MPA in dogs with PH [35, 74–77].
Right pulmonary artery distensibility index (RPADi) is the difference in 
diameters of the right pulmonary artery (RPA) at systole and diastole obtained 
from either M-mode right parasternal short-axis (Figure 11A and B) or long-axis 
four-chamber view (Figure 12A) of PA [77, 80]. One canine study suggested that a 
RPADi <35 is indicative of PH, while values of 28–35, 23–27, and <23 are indicative 
of mild (30–55 mmHg), moderate (56–79 mm Hg), and severe PH (>79 mm Hg), 
respectively [80]. Further study also found that the RPADi was closely correlated 
with the sPAP [77]. However, the reference range of RPADi was significantly differ-
ent, depending on the echocardiographic views [77, 80].
RVOT-%FS indicates RV systolic function and can be obtained from M-mode 
measurement of the RVOT of the right parasternal short-axis view at the level 
of the aortic root using the following formula: ([RVOT dimensions at end-dias-
tole − RVOT dimensions at end-systole]/RVOT dimensions at end-diastole) × 100 
(Figure 12B) [81]. One recent canine study found the RVOT-%FS is significantly 
decreased (<45%) in dogs with PH [82]. However, the RVOT-%FS can be affected 
by other diseases causing RV systolic dysfunction.
Figure 11. 
2D echocardiographic interrogation of pulmonary hypertension. (A and B) right pulmonary artery 
distensibility index (RPADi) is the difference in diameters of the right pulmonary artery (RPA) at systole 
(A) and diastole (B) obtained from either 2D or M-mode echocardiography at a right parasternal short axis 
of PA. (C) Left ventricular (LV) eccentricity obtained from right parasternal short-axis view at papillary 
level (a ratio of longitudinal to the transverse length of LV chamber). (D) The ratio of main pulmonary 
artery diameter to aortic root diameter obtained at a right parasternal short axis of PA. (See text for more 
information).
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Tricuspid annular plane systolic excursion (TAPSE) also reflects RV systolic 
function, which can be significantly affected by RV pressure overload [83]. Recent 
canine studies found dogs with PH had lower TAPSE, indicating pressure overload 
in the RV chamber [75, 84]. The TAPSE can be obtained from M-mode echocar-
diography that aligned the beam to the lateral tricuspid annulus in the left apical 
long-axis four-chamber view by calculating the maximal and the minimal excursion 
of lateral tricuspid annulus motion (Figure 12C) as similar to the measurement of 
mitral annular plane systolic excursion (MAPSE; Figure 12D). However, the TAPSE 
is influenced from the size of dogs; recent studies used body weight-normalized 
TAPSE (nTAPSE = TAPSE/[BW(kg)]1/3) and TAPSE to Ao ratio to overcome 
the influence of body size [82, 85]. The median (range) of nTAPSEs were 0.60 
(0.53–0.66) in ACVIM B1, 0.71 (0.64–0.84) in B2, and 0.73 (0.58–0.80) in C and 
D MMVD dogs [85]. Other study found the TAPSE/Ao ratio was closely correlated 
with the size of the LA in dogs with MMVD and PH [82]. The TAPSE/Ao ratio <0.65 
was indicative of the presence of PH in dogs with MMVD, although it showed low 
sensitivity for detecting PH [82].
5.3 Doppler interrogation of PA flow profiles and related variables
Several studies evaluated quantitative echocardiographic variables related to 
PH in humans and dogs [78, 86–89]. Among those echocardiographic variables, 
PW Doppler-derived acceleration time to peak PA flow velocity (AT), AT to the 
ejection time of PA flow ratio (AT/ET) (Figure 13A) [86], the right ventricular Tei 
Figure 12. 
2D and M-mode echocardiographic interrogation of pulmonary hypertension. (A) Right pulmonary artery 
distensibility index (RPADi) can be obtained from a right parasternal long axis of four-chamber plane 
(arrow). (B) Right ventricular outflow tract fractional shortening (RVOT-%FS) obtained from M-mode 
measurement of the RVOT of the right parasternal short-axis view at the level of the aortic root. Tricuspid 
(TAPSE; C) and mitral (MAPSE; D) annular plane systolic excursion obtained from a left apical  
four-chamber plane of M-mode echocardiography. (See text for more information).
Echocardiography
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index (RV Tei) (Figure 13B and D) [89], and Doppler pulmonic outflow profiles 
(Figure 13C) [90] are being used to interrogate PH in dogs. One study found AT, 
AT/ET ratio, and RV Tei index are strongly correlated with sPAP in dogs without 
detectable PR [35]. Especially, AT/ET ratios ≤0.25 were predictive of PH, whereas 
AT/ET ratios >0.42 ruled out PH [86]. However, other study found Doppler esti-
mated mPAP was strongly associated with AT and AT/ET, but weakly associated 
with RV Tei index [90]. Over 50% of dogs in International Small Animal Cardiac 
Health Council (ISACHC) II and III had equivocal value of AT/ET indicating PH 
(0.25–0.42) in this study, suggesting low sensitivity for detecting PH, although 
most dogs having <0.25 had detectible TR or PR on echocardiography, indicating 
high specificity for detecting clinically significant PH [90]. This study also found 
Doppler pulmonic outflow profiles were closely associated with severity of PH 
in dogs with MMVD, since the Doppler pulmonic outflow profiles (type I/II/III) 
were 18/0/0 in control, 22/5/1 in ISACHC I, 21/24/2 in ISACHC II, and 17/40/4 in 
ISACHC III MMVD dogs [90]. The PW Doppler-derived echocardiographic vari-
ables of PA flow may have limited value in dogs with hyperdynamic RV condition 
because Doppler pulmonic outflow profiles can be influenced by RV loading condi-
tions and systolic function [90]. Although RV-TDI may not be a direct indicator 
of PH, it can be used to evaluate RV systolic and diastolic function in PH patients. 
It can be obtained from the basal segment of the internal mid-portion of the RV 
wall in the left parasternal long-axis four-chamber view (Figure 13D). One study 
evaluated the diagnostic value of peak RV myocardial velocities at systole (Stdi), 
early (Etdi), and late (Atdi) diastole [35]. Also the global TDI index was calculated 
using the following formula in this study: global TDI index = Stdi × Etdi/Atdi [35]. 
Figure 13. 
Pulse-wave and tissue Doppler interrogation of pulmonary hypertension. (A) PW Doppler-derived 
acceleration time (AT) to peak pulmonary artery (PA) flow velocity (AT), AT to the ejection time (ET) of 
PA flow ratio (AT/ET). (B) Tissue Doppler-derived right ventricular Tei index (RV Tei), (C) PW Doppler-
derived pulmonic outflow profiles, (D) PW Doppler-derived RV Tei index. (See text for more information).
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This study demonstrated the decrement of the global TDI index and Etdi/Atdi in 
dogs with PH [35]. Furthermore, global TDI index of <11.8 showed sensitivity of 
89% and specificity of 90%, while Etdi/Atdi of <1.12 showed sensitivity of 89% and 
specificity of 93% for detecting PH in the study population [35].
6. Assessment of cardiac chamber deformation/dyssynchrony
Strain and strain rate imaging is an advanced echocardiographic technique 
for estimating myocardial segmental deformation, respectively [12, 91]. 
Myocardial strain (i.e., deformation of a myocardial segment over time; % 
change from its original dimension) and strain rate (the rate of myocardial 
deformation; S−1) can evaluate more direct intrinsic myocardial function and 
are less angle-dependent than TDI-based methods [92–94]. Strain and strain 
rate can be obtained from LV, LA, and RV wall using STE, feature-tracking 
echocardiography (FTE), or color TDI technology in the longitudinal, radial, 
and circumferential planes (Figure 14) [83]. Speckle tracking can detect the 
degree of myocardial deformation from the continuous frame-by-frame tracking 
of speckles (acoustic markers). By tracking these speckles in the myocardium 
throughout the cardiac cycle, the direction and velocity of myocardial motion 
can be determined. By comparing the motion of each speckle, the degree of 
deformation on each segment of the myocardium can be assessed.
Although precise assessment of LV systolic dysfunction is critical for therapeutic 
intervention and prediction of progression of CHF in dogs with MMVD, assess-
ment of LV function using conventional echocardiography is often complicated 
Figure 14. 
Representative images of left atrial (LA) and ventricular (LV) strain and strain rate imaging for LA and LV 
deformation analysis in dogs with mitral regurgitation. (A and B) LV (A) and LA (B) strain profiles obtained 
from GE analysis software algorithm (EchoPAC). (C and D) LV (C) and LA (D) strain profiles obtained from 
Siemens vector velocity imaging (VVI). (See text for more information).
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with loading conditions [95]. Several studies demonstrated strain and strain rate 
obtained from the 2D-STE were useful to grade the progression of dogs with 
MMVD [95–98]. One study claimed the longitudinal strain with the GE analysis 
software algorithm (EchoPAC) was inconsistent and less repeatable, while radial 
strain curves from short-axis images were more consistent and more repeatable 
(Figure 14A and B) [95]. Since the software algorithm for strain is automated, 
special attention should be focused on “(1) timing of the ECG to select the cardiac 
cycle and the onset and duration of analysis; (2) tracing of the endocardial border 
for automated detection; (3) inspecting the region of interest; (4) following the 
tissue tracking in real-time and slow-motion; and (5) inspecting the generated 
curves relative to the R-waves and aortic valve closure (AVC)” as described in Smith 
et al. [95]. A velocity vector imaging (VVI) is another form of strain analysis, which 
can display tissue velocity as a vector showing the amplitude and direction of the 
movement (Figure 14C and D) [99].
Atrial myocardial deformation profiles estimated by TDI and 2D-STE (e.g. 
strain and strain rate) have been recently emerged as a good alternative method 
of exploring LA mechanics in both humans and dogs [100–103]. Although many 
drawbacks of this approach were noticed (e.g. suboptimal reproducibility, angle 
dependence, and the confounding effect of noise artifacts), 2D-STE can be a 
more advanced angle-independent echocardiographic technique for the direct 
evaluation of LA function than standard grayscale echocardiographic images 
[100–103]. The specific STE variables subject to the LA function include peak 
atrial longitudinal average strain (PALS), peak atrial contraction average strain 
(PACS), and contraction strain index (CSI), which reflect the LA function during 
its reservoir, booster pump phase, and the contribution of LA active contraction 
to the LV filling phase (Figure 14B) [104]. In humans, LA strain analysis has 
been useful for grading patients with valvular diseases, atrial fibrillation, or acute 
coronary disease [105–107]. However, a recent canine study found the STE vari-
ables were not significantly different between ACVIM B1 and B2 groups, although 
those (especially, PALS) were significantly different between ACVIM B2 and C 
groups [108]. The use of cut-off for PALS <27.9% enables to perfectly differentiate 
dogs in ACVIM stage B2 from those in ACVIM stage C with a sensitivity of 100% 
and specificity of 100% [108]. Another study also demonstrated the STE variables 
including PALS, PACS, and CSI were significantly decreased with the progres-
sion of MMVD [103]. A further study from this study group also found the STE 
variables (PALS <30% and CSI per 1% increase) were predictors of cardiac death 
in the univariate analysis [109].
Since the RV chamber is crescent-shaped and is wrapped around the LV, precise 
echocardiographic assessment of RV function is often difficult. The TDI and STE 
can overcome this limitation as reported in human studies [110, 111]. Recent canine 
study found the STE on RV was applicable and repeatable in healthy dogs [93]. 
Furthermore, other study demonstrated the RV longitudinal strain and the dys-
synchrony index were significantly different from control dogs [75]. In this study, 
the global, free wall, and septal RV longitudinal strain in dogs with precapillary PH 
were significantly lower than those in control, while free wall and septal systolic 
shortening time strain were significantly slower [75].
7. Conclusion
In this chapter, we described echocardiographic features of MMVD in dogs 
along with human echocardiographic criteria of MR. Although there are many 
similarities for diagnosing and grading the severity of MR in both species, 
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veterinary cardiologists are more focused on the severity of cardiac remodel-
ing and cardiac dysfunction caused by MR, because surgical restoration of 
defected mitral apparatus is rarely done in dogs. Recent canine studies also found 
advanced ultrasound technologies, such as strain and strain rate imaging, and 
two-dimensional speckle tracking echocardiography were also applicable for dogs 
with MMVD, although more studies are warranted for standardizing the method 
of assessment in dogs. The authors believe that this chapter would be a valuable 
reference for veterinary and human cardiologists and researchers for understand-
ing mitral valve disease.
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